Bevacizumab, known generically as Bevacizumab Injection, requires regular hospital visits for medication and is usually hospitalized for 2 days and discharged without significant discomfort. Bevacizumab Injection is used in combination with other drugs for the treatment of metastatic colorectal cancer and advanced, metastatic or recurrent non-small cell lung cancer. This product requires regular hospital visits to administer the medication, which is given every 2 weeks or every 3 weeks. Hospitalization is usually required for about 2 days for each dose because of the need to prepare the medication in the hospital and to observe the patient after administration. Adverse reactions commonly occurring with this product include peripheral sensory neuropathy, hypertension, leukopenia, neutropenia, thrombocytopenia, etc. It is contraindicated for those who are allergic to this product. Please follow the doctor’s instructions to the hospital on a regular basis to use the drug, if there is obvious discomfort after the administration of the drug, please inform the physician.